Search research articles
Contact Us
Filters
Showing results (91-100 of 171) with videos related to
Page
of 18
Sort By:
Circulation. Genomic and Precision Medicine
|
February 17, 2018
Impact of Apolipoprotein(a) Isoform Size on Lipoprotein(a) Lowering in the HPS2-THRIVE Study
Sarah Parish, Jemma C Hopewell, Michael R Hill, et al.
European Heart Journal
|
April 12, 2007
Anticoagulants in heart disease: current status and perspectives
Raffaele De Caterina, Steen Husted, Lars Wallentin, et al.
Clinical Kidney Journal
|
December 8, 2018
The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY study
William G Herrington, David Preiss, Richard Haynes, et al.
Kidney International
|
November 18, 2017
Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation
Benjamin C Storey, Natalie Staplin, Richard Haynes, et al.
European Heart Journal
|
July 24, 2020
Independent risk factors for simvastatin-related myopathy and relevance to different types of muscle symptom
Jemma C Hopewell, Alison Offer, Richard Haynes, et al.
Kidney International
|
February 4, 2018
Declining comorbidity-adjusted mortality rates in English patients receiving maintenance renal replacement therapy
Benjamin C Storey, Natalie Staplin, Charlie H Harper, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
November 25, 2015
Cost-effectiveness of Simvastatin plus Ezetimibe for Cardiovascular Prevention in CKD: Results of the Study of Heart and Renal Protection (SHARP)
Borislava Mihaylova, Iryna Schlackow, William Herrington, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
March 15, 2014
The effect of lowering LDL cholesterol on vascular access patency: post hoc analysis of the Study of Heart and Renal Protection
William Herrington, Jonathan Emberson, Natalie Staplin, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
January 31, 2023
Fibroblast Growth Factor-23 and Risk of Cardiovascular Diseases: A Mendelian Randomization Study
Killian Donovan, William G Herrington, Guillaume Paré, et al.
Kidney International
|
February 3, 2023
Interference of urinary albumin-to-creatinine ratio measurement by glycosuria: clinical implications when using SGLT-2 inhibitors
Daniel Chapman, Parminder K Judge, Rebecca J Sardell, et al.
Page
of 18
Search research articles
Search
Showing results (91-100 of 171) with videos related to
Sort By:
Page
of 18
Circulation. Genomic and Precision Medicine
|
February 17, 2018
Impact of Apolipoprotein(a) Isoform Size on Lipoprotein(a) Lowering in the HPS2-THRIVE Study
Sarah Parish, Jemma C Hopewell, Michael R Hill, et al.
European Heart Journal
|
April 12, 2007
Anticoagulants in heart disease: current status and perspectives
Raffaele De Caterina, Steen Husted, Lars Wallentin, et al.
Clinical Kidney Journal
|
December 8, 2018
The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY study
William G Herrington, David Preiss, Richard Haynes, et al.
Kidney International
|
November 18, 2017
Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation
Benjamin C Storey, Natalie Staplin, Richard Haynes, et al.
European Heart Journal
|
July 24, 2020
Independent risk factors for simvastatin-related myopathy and relevance to different types of muscle symptom
Jemma C Hopewell, Alison Offer, Richard Haynes, et al.
Kidney International
|
February 4, 2018
Declining comorbidity-adjusted mortality rates in English patients receiving maintenance renal replacement therapy
Benjamin C Storey, Natalie Staplin, Charlie H Harper, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
November 25, 2015
Cost-effectiveness of Simvastatin plus Ezetimibe for Cardiovascular Prevention in CKD: Results of the Study of Heart and Renal Protection (SHARP)
Borislava Mihaylova, Iryna Schlackow, William Herrington, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
March 15, 2014
The effect of lowering LDL cholesterol on vascular access patency: post hoc analysis of the Study of Heart and Renal Protection
William Herrington, Jonathan Emberson, Natalie Staplin, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
January 31, 2023
Fibroblast Growth Factor-23 and Risk of Cardiovascular Diseases: A Mendelian Randomization Study
Killian Donovan, William G Herrington, Guillaume Paré, et al.
Kidney International
|
February 3, 2023
Interference of urinary albumin-to-creatinine ratio measurement by glycosuria: clinical implications when using SGLT-2 inhibitors
Daniel Chapman, Parminder K Judge, Rebecca J Sardell, et al.
Page
of 18